Pennsylvania 30 Hour Pharmacy CE Requirement Package
Included Courses
Courses included in this package. Click on a course to learn more.
-
Child Abuse Identification and Reporting: The Pennsylvania Requirement 3
Course release date: 12/1/2024
Course Overview
In 2020, there were 4,593 substantiated reports to child abuse in Pennsylvania. Healthcare professionals, regardless of their discipline or field, are in a unique position to assist in the identification, education, and prevention of child abuse and neglect. This course describes how victims of abuse can be accurately identified and provides the community resources available in the state of Pennsylvania for child abuse victims. Mandated reporter laws will also be outlined. -
Patient Safety and Medication Errors for Pharmacy Professionals 2
Course Release: 4/1/2024
About the course
This educational program is designed to accomplish at least two important goals: first to provide examples of critical potential medication errors, and secondly to offer mechanisms that pharmacy professionals can take to intervene in these mishaps and enhance patient care. In addition to offering these critical examples and potential solutions, two case studies are included to help put some of the ideas into realistic scenarios similar to those that may be encountered in contemporary pharmacy practice. Evidence-based practice information from current peer-reviewed literature is also included for context and ideas for pharmacists to consider in efforts to improve their practice appear throughout the program. Lastly, a post-test is included at the end of the program to test your understanding of the material.
-
Antibiotic Stewardship, 2nd Edition 2
Course release date: 4/23/2025
Course Overview
The introduction of antibiotics into the practice of medicine has transformed the lives of millions of people. Infections that were once lethal are now easily treatable, and medical advances have been able to move forward through the use of antibiotics. Unfortunately, approximately 30% of all antibiotics administered in hospitals in the United States have been deemed either unnecessary or inappropriate (Centers for Disease Control and Prevention [CDC], 2024a). The misuse of antibiotics has contributed to increases in the rates of Clostridium difficile infections and adverse reactions to antibiotics, as well as the development of resistant strains of bacteria. The CDC estimates that approximately 35,000 deaths annually are caused by antibiotic-resistant organisms (CDC, 2024b).
Inappropriate prescribing of antibiotics is considered a significant public health and patient safety issue. An increasing amount of evidence supports the use of antibiotic stewardship programs to enhance the treatment of infections and decrease adverse events associated with the use of antibiotics. Antibiotic stewardship programs can help prescribers improve patient safety and the quality of patient care by improving infection cure rates, decreasing the rate of treatment failures, increasing the rate of correct antibiotic prescribing, reducing hospital rates of antibiotic resistance and C. difficile infections, as well as increasing cost savings (CDC, 2024a, 2024b).
-
Diabetes Technology 2
Course Release Date: 1/6/2025
Course Overview
This course is intended to be used by primary care providers and practitioners as an update on the ever-changing landscape of diabetes technology, including continuous glucose monitors and insulin pumps. The course will review new updates to the technology as well as provide clinicians with a real-world case to help them feel comfortable managing insulin pump patients in primary care.
-
Diets and Dietary Approaches to Weight Loss 4
Course release date: 8/1/2024
Course Overview
The most important consideration for a patient that is attempting to lose weight is the long-term sustainability of the diet for that specific individual. Although some of the diets discussed here might produce impressive results initially, extreme diets in any form do not usually work long-term. The most effective diets are those that people can live with day in and day out for the rest of their lives. This course will outline various approaches to diets and dietary modifications, with a focus on the impact of these approaches on weight. -
Genital Mycoplasma Infections: Unrecognized STIs 4
Course release date: 3/28/2025
Course Overview
Genital mycoplasma infections are a significant source of morbidity for sexual partners. Genital mycoplasma species include: Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, and Mycoplasma genitalium. These organisms can cause pelvic inflammatory infections, recurrent bacterial vaginitis, and recurrent urinary tract infections. Some have been linked to pregnancy complications, neonatal infections, and infertility. In men, they most often present as nongonococcal urethritis and can lead to orchitis. One species, M. genitalium, was labeled a sexually transmitted infection (STI) in 2015 by the CDC. Despite these risks and the STI label, many providers have never heard of genital mycoplasmas and, if they have, discount their morbidity. When recognized (mostly in men) rarely is their partner treated, leading to both being re-infected. Recognizing and treating these infections would relieve a significant amount of human suffering. This presentation will cover how to recognize, identify, diagnose, and treat mycoplasma infections. -
Substance Use Disorders and Pain Management: MATE Act Training 8
Course release date: 5/1/2026
Course Overview
Substance use disorders continue to be an important health issue in the United States and can lead to significant problems in all aspects of a person's life. Appropriate assessment and management of substance use is a priority in patient care. In addition, the presence of substance use disorders can complicate the treatment or management of comorbid medical conditions. Given the ongoing prescription opioid (and illicitly manufactured fentanyl) use and overdose epidemic in the United States and the widespread incidence of chronic pain, opioid prescribing and optimum safe pain management is a public health concern. All clinicians should have good knowledge of the available options for substance use disorder treatment and for safe opioid prescribing and dispensing. -
Telepharmacy: Serving Underserved Populations in a Community Setting 2
Release Date: 1/26/2021
About the Course:
Telepharmacy is a growing practice model in many states and a hot topic within the pharmacy community and among lawmakers and regulators. Rapidly advancing technology allows pharmacists to serve underserved populations remotely. Yet telepharmacy practice is still in its infancy; its relative newness and the many variations among state regulations leaves many pharmacists, pharmacy technicians, and other healthcare stake holders unclear about the details and various uses of telepharmacy practice. This course reviews the current landscape of telepharmacy practice and regulations, telepharmacy technology and workflow, remote oversight of advanced pharmacy technicians, and patient care through telepharmacy -
Understanding the FDA’s Medication Safety Initiatives 4
Course Release: 1/9/2024
About the course
In 2022 over 6.7 billion prescriptions were dispensed (Matej Mikulic, 2023, September 15). This number increases each year. The U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER) agency is responsible for approving, monitoring, educating, and evaluating the safety and effectiveness evaluation of both prescription and over-the counter drugs as well as medical devices. This course presents an overview of the FDA’s history, its current role in safety monitoring, drug effectiveness, and supply of medications in the United States. The agency maintains many different databases and publications related to drug safety and availability which are available to both the healthcare professionals and consumers. As healthcare providers, it is critical to understand many of these resources and to know which ones are applicable to your profession. This course provides an overview of many of the important resources that the FDA provides as well as how to access the information, how to report concerns and how to stay current as the landscape of drug availability continually changes in the United States.